IMAC Holdings Inc. has announced the appointment of Jason Lobel and Saundra Pelletier to its Board of Directors as of June 2, 2025. Jason Lobel brings experience as a serial entrepreneur and CEO of GenomicMD, while Saundra Pelletier is recognized for her expertise in women's health and her leadership role at Evofem Biosciences, Inc. Their appointments are expected to enhance the company's strategic direction and leadership.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.